Starry Pharm is the largest manufacturer of X-CT non-ionic and MRI Contrast Medium in China. Main products have GMP certificate, COS and Japanese PMDA qualified and so on. At present, the integrated layout of intermediates, APIs, and preparations has been completed, and the finished products of iohexol, iopamidol, iodixanol and iomeprol injection have passed the consistency evaluation, and particularly iomeprol injection is the first generic in China
more >
Year of Establishment:
1997
Total Number of Staff:
more than 500
Main Competitive Advantages:
International Approvals/Standards,Experienced R&D Staff,Delivery Term,Production Capacity,Buyers´ Specifications Accepted,Small Orders Accepted,Reputation,Quality Service
Other Competitive Advantages:
Patents and Copyrights:
Business Type:
Manufacturer
R&D capacity:
Annual Turnover(USD):
75,000,000 to 79,999,999
Main Sales Markets:
Central/South America,Eastern Europe,Asia,Middle East
Advantage Description: